middle.news
Optiscan Brings InVue Real-Time Surgical Imaging to FDA Review
9:13am on Monday 5th of October, 2026 AEDT
•
Medical Technology
Read Story
Optiscan Brings InVue Real-Time Surgical Imaging to FDA Review
9:13am on Monday 5th of October, 2026 AEDT
Key Points
InVue 510(k) application lodged with the US FDA
Device targets real-time, cellular-level imaging during surgery
Submission follows Optiscan’s InForm FDA application
FDA may request further information before deciding
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Optiscan Imaging (ASX:OIL)
OPEN ARTICLE